Category: St. Jude Medical
Here's a look at some of the top legal news stories for medical device companies this week: Appeals court upholds Gore win over St. Jude Medical; Independent legal panel rejects Infuse allegations in Medtronic shareholder suits; Judge dismisses Anulex from Xclose off-label lawsuit; Appeals court upholds Abiomed win in shareholder's class action; Convicted ex-Heart Tronics CEO won't get a retrial, judge rules.
Here's a look at some of the top Wall Street stories for medical device companies this week: Medtronic, Johnson & Johnson park billions in offshore accounts; Philips, Teva ink Israeli medtech incubator JV; Allergan board members unanimously reject Valeant's $53B offer; Convicted ex-Heart Tronics CEO won't get a retrial, judge rules.
, Heart Tronics
, Johnson & Johnson
, Pershing Capital Management
, Philips Healthcare
, Securities & Exchange Commission (SEC)
, St. Jude Medical
, Teva Pharmaceuticals
, Valeant Pharmaceuticals
, Abbott Laboratories
, Allergan Inc.
A federal appeals court upholds W.L. Gore & Assoc.'s win over St. Jude Medical in their patent spat over heart defect repair technology.
A federal appeals court today upheld a win for W.L. Gore & Assoc. in a patent war with St. Jude Medical (NYSE:STJ) over heart defect repair technology.
Some of medtech's largest players, including Medtronic, Johnson & Johnson and Abbott, rank high on the list of companies with the most money housed in offshore tax havens, according to a new report.
There are no awards handed out for companies with the most money housed in overseas accounts, but keeping cash in tax havens is its own reward for at least a dozen top medical device makers, according to a new study.
A federal judge sends a $570 million lawsuit filed against Boston Scientific by the family of Dr. Michel Mirowski, credited with inventing the implantable cardioverter defibrillator, back to a Maryland state court.
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
St. Jude Medical says it's complete its $455 million acquisition of CardioMEMS and its Champion HF implantable heart monitor, just days after FDA approval of the device.
St. Jude Medical (NYSE:STJ) wasted no time in closing its acquisition of CardioMEMS, days after the FDA approved the Champion HF implantable heart monitor, saying it plans to begin a "strategic" launch of the device in the U.S.